Balanced news tone
News Sentiment
MLAB sentiment intelligence
Mesa Laboratories Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-9.4% over one week, -9.4% over four weeks, trend active, and near fair-value range.
Inventory turnover of Mesa Laboratories, Inc. – GETTEX:MLI
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Inventory turnover of Mesa Laboratories, Inc. – GETTEX:MLI
This article provides financial information for Mesa Laboratories, Inc. (GETTEX:MLI), specifically focusing on its inventory turnover. The content is presented as part of TradingView's financial data offerings, indicating its relevance to investors tracking company performance.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 03:10
- Source
- TradingView
Long Path (MLAB) holds 8.6% of Mesa Laboratories, 477,126 shares
Long Path-affiliated entities have reported an 8.6% stake in Mesa Laboratories (MLAB), totaling 477,126 shares of common stock. This beneficial ownership, which includes Long Path Smaller Companies Fund, Long Path Fund GP, Long Path Partners, Long Path Holdings LLC, William Thoma
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 07 Jul 2026 20:09
- Source
- Stock Titan
Mesa Laboratories And 2 Other Companies That May Be Priced Below Their Estimated Value
This article identifies Mesa Laboratories (MLAB), Live Oak Bancshares (LOB), and Rush Street Interactive (RSI) as potentially undervalued stocks based on their estimated future cash flows compared to current prices. It highlights their growth prospects, financial health, and spec
- Tone
- Positive 74/100
- Event
- Balance sheet
- Published
- 07 Jul 2026 17:14
- Source
- Simply Wall Street
Mesa Laboratories focuses on reliable measurement solutions for regulated industries
Mesa Laboratories specializes in providing measurement instruments and services for highly regulated industries, focusing on compliance and long-term reliability. The company's solutions help organizations monitor and document critical processes, ensuring product quality and safe
- Tone
- Positive 76/100
- Event
- Market update
- Published
- 07 Jul 2026 13:42
- Source
- AD HOC NEWS
Mesa Labs sets $0.16 quarterly dividend, payable Sept. 15
Mesa Labs (NASDAQ: MLAB) announced a regular quarterly dividend of $0.16 per share for its common stock. The dividend is scheduled to be paid on September 15, 2026, to shareholders of record as of August 31, 2026. The company specializes in designing and manufacturing life scienc
- Tone
- Positive 64/100
- Event
- Capital return
- Published
- 06 Jul 2026 14:10
- Source
- Stock Titan
Mesa Labs declares $0.16 quarterly dividend payable Sept. 15 By Investing.com
Mesa Laboratories, Inc. (NASDAQ:MLAB) has declared a quarterly dividend of $0.16 per share, payable on September 15, 2026, to shareholders of record as of August 31, 2026. The company has a 24-year history of dividend payments, and its stock has surged 35% year-to-date, trading a
- Tone
- Positive 61/100
- Event
- Capital return
- Published
- 06 Jul 2026 14:10
- Source
- Investing.com Canada
Mesa Laboratories Keeps Quarterly Dividend at $0.16 per Share, Payable Sept. 15 to Shareholders of Record Aug. 31
Mesa Laboratories, Inc. announced that it will keep its regular quarterly dividend at $0.16 per share. This dividend is payable on September 15, 2026, to shareholders who are on record as of August 31, 2026. The announcement was made on July 6, 2026.
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 06 Jul 2026 14:10
- Source
- www.marketscreener.com
Mesa Laboratories Declares Regular Quarterly Dividend of $0.16 per Share
Mesa Laboratories (MLAB) has declared a regular quarterly dividend of $0.16 per share, payable on September 15, 2026, to shareholders of record by August 31, 2026. The company, a leader in life science tools and quality control, noted that despite this positive financial step, fo
- Tone
- Positive 64/100
- Event
- Capital return
- Published
- 06 Jul 2026 14:00
- Source
- Quiver Quantitative
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. This dividend will be payable on September 15, 2026, to shareholders of record as of August 31, 2026. The company is a global
- Tone
- Positive 71/100
- Event
- Capital return
- Published
- 06 Jul 2026 09:50
- Source
- GlobeNewswire
MLAB Stock Price and Chart — NASDAQ:MLAB
This article provides a comprehensive overview of Mesa Laboratories, Inc. (MLAB) stock, including its current price, historical performance, key financial statistics, and upcoming earnings dates. It details the company's various operating segments within the health technology sec
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 Jul 2026 17:42
- Source
- TradingView
MLAB - Mesa Laboratories Inc Latest SEC Filings
This article provides the latest SEC filings information for Mesa Laboratories Inc (MLAB), detailing its financial metrics, stock performance data, and other key company statistics. It includes financial figures like market cap, income, sales, P/E ratio, dividend information, and
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 05 Jul 2026 17:10
- Source
- Finviz
Price to book forward of Mesa Laboratories, Inc. – NASDAQ:MLAB
This article provides the "Price to book forward" value for Mesa Laboratories, Inc. (NASDAQ: MLAB). The content indicates a specific period and its corresponding value, along with change and percentage change. The article focuses solely on this financial metric for the company.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 14:13
- Source
- TradingView
Enterprise value to EBITDA forward of Mesa Laboratories, Inc. – NASDAQ:MLAB
This article focuses on the enterprise value to EBITDA (forward) for Mesa Laboratories, Inc. (NASDAQ: MLAB). It appears to be a financial data snippet from a larger platform rather than a detailed analysis, providing a specific financial metric for the company.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 06:09
- Source
- TradingView
Price to earnings forward of Mesa Laboratories, Inc. – MUN:MLI
This article provides the "Price to earnings forward" value for Mesa Laboratories, Inc. (MUN:MLI). The content is primarily a header and mentions that the market is currently closed with no trades. It also details various products, communities, and services offered by TradingView
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Jun 2026 02:10
- Source
- TradingView
Price to sales forward of Mesa Laboratories, Inc. – MUN:MLI
This article provides the "price to sales forward" value for Mesa Laboratories, Inc. (MUN:MLI). The financial data is noted as being provided by ICE Data Services and FactSet, with SEC filings from Quartr. Details regarding the specific financial value are presented within the ma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 20:40
- Source
- TradingView
Price to earnings forward of Mesa Laboratories, Inc. – NASDAQ:MLAB
This article provides the "Price to earnings forward" metric for Mesa Laboratories, Inc. (NASDAQ: MLAB). The content primarily consists of navigation and boilerplate text from the TradingView platform, noting that the market is closed and no trades have occurred for the stock.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jun 2026 18:40
- Source
- TradingView
Mesa Laboratories, Inc. Actuals & Estimates (NASDAQ:MLAB)
This article provides an overview of Mesa Laboratories, Inc. (MLAB) stock performance, financial actuals, and analyst estimates. It includes current stock price, historical highs and lows, market capitalization, volatility, and details on recent earnings and revenue. The report a
- Tone
- Positive 61/100
- Event
- Earnings
- Published
- 26 Jun 2026 16:09
- Source
- TradingView
MLAB Forecast — Price Target — Prediction for 2027
This article provides a forecast for Mesa Laboratories, Inc. (MLAB) stock, including analyst price targets, historical performance data, and financial metrics. It highlights that analysts have a one-year price target ranging from $94.00 to $130.00 and details the company's recent
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 25 Jun 2026 16:40
- Source
- TradingView
Form 4 Mesa Laboratories Inc For: 23 June By Investing.com
This article reports on a Form 4 filing for Mesa Laboratories Inc., dated June 23, with a publication date of June 24, 2026. The content is primarily a placeholder or an auto-generated reporting piece from Investing.com, accompanied by various market data and news headlines. It i
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 12:40
- Source
- Investing.com Australia
Mesa Labs SVP Brian Archbold sells $225k in stock after RSU conversion By Investing.com
Brian Archbold, Senior Vice President of Operations at Mesa Laboratories Inc. (NASDAQ:MLAB), sold 2,516 shares of company stock for approximately $225,187 after converting restricted stock units and performance share units. The sale occurred on June 22, 2026, following recent acq
- Tone
- Negative 42/100
- Event
- Market update
- Published
- 24 Jun 2026 12:11
- Source
- Investing.com South Africa
Mesa Labs SVP Brian Archbold sells $225k in stock after RSU conversion
Brian David Archbold, SVP of Operations at Mesa Laboratories Inc. (NASDAQ:MLAB), sold approximately $225,187 worth of stock after converting restricted stock units and performance share units. The sale involved 2,516 shares at $89.502 per share on June 22, 2026. This followed his
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 23 Jun 2026 23:10
- Source
- Investing.com
Mesa Labs CAO Crennen sells $39,559 in MLAB shares
Mesa Laboratories' Chief Accounting Officer, Lyndsey Elizabeth Crennen, sold 442 shares of MLAB stock worth $39,559 to cover taxes on vested Restricted Stock Units and Performance Share Units. Prior to this sale, Crennen acquired 989 shares through RSU conversions and performance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 19:40
- Source
- Investing.com
Mesa Laboratories (MLAB) CAO reports RSU vesting and 442-share tax sale
Mesa Laboratories' CAO, Lyndsey Elizabeth Crennen, reported the vesting of restricted stock units (RSUs) and performance share units (PSUs), resulting in 726 shares of common stock and an additional 263-share grant. Subsequently, Crennen sold 442 shares of common stock at $89.502
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 17:40
- Source
- Stock Titan
Mesa Laboratories (MLAB) CFO reports grants, RSU conversions and tax-cover share sale
Mesa Laboratories CFO John Sakys recently engaged in several equity transactions, including receiving a grant of 2,282 shares and exercising restricted stock units (RSUs) that converted into 3,792 shares in total. He subsequently sold 2,827 shares at an average price of $89.502 p
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 16:40
- Source
- Stock Titan
Mesa Laboratories (MLAB) SVP exercises RSUs and sells 2,516 shares
Brian David Archbold, Senior Vice President of Operations at Mesa Laboratories (MLAB), recently engaged in significant stock transactions. He exercised restricted stock units (RSUs) for 3,324 shares and received an additional grant of 1,859 shares. Following these acquisitions, A
- Tone
- Negative 37/100
- Event
- Deals and strategy
- Published
- 23 Jun 2026 16:40
- Source
- Stock Titan
Form 144 MESA LABORATORIES INC /CO/ For: 22 June By Investing.com
This article announces the filing of Form 144 for MESA LABORATORIES INC /CO/ on June 22nd. Form 144 is a notice of the intent to sell restricted securities. The brief notice was published by Investing.com.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 20:39
- Source
- Investing.com Nigeria
MLAB (NASDAQ: MLAB) insider sale notice — 2,516 shares disclosed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
MLAB (NASDAQ: MLAB) files Rule 144 for 2,827 vested shares via Fidelity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
Mesa Laboratories: Priced for the Problem, Not the Platform
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 08:42
- Source
- GuruFocus.com
Mesa Laboratories stock (US59064R1095): steady niche player after latest quarterly results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jun 2026 17:20
- Source
- Ad Hoc News